1. Home
  2. CRNX vs MHH Comparison

CRNX vs MHH Comparison

Compare CRNX & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$38.38

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo Mastech Digital Inc

MHH

Mastech Digital Inc

HOLD

Current Price

$6.23

Market Cap

81.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
MHH
Founded
2008
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
81.7M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
CRNX
MHH
Price
$38.38
$6.23
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$76.63
N/A
AVG Volume (30 Days)
1.1M
8.9K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
$1,039,000.00
$191,371,000.00
Revenue This Year
$720.10
$2.93
Revenue Next Year
$184.67
$8.93
P/E Ratio
N/A
$116.20
Revenue Growth
N/A
N/A
52 Week Low
$24.10
$5.51
52 Week High
$57.99
$9.02

Technical Indicators

Market Signals
Indicator
CRNX
MHH
Relative Strength Index (RSI) 50.79 55.20
Support Level $33.19 $5.52
Resistance Level $45.32 $7.59
Average True Range (ATR) 1.72 0.42
MACD 0.67 0.03
Stochastic Oscillator 92.34 64.49

Price Performance

Historical Comparison
CRNX
MHH

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

Share on Social Networks: